SUMO1 and gastric carcinoma: To determine how downregulation of SUMO affects EBV reactivation and lytic infection, SUMO1 was silenced in AGS gastric carcinoma cells latently infected with EBV (AGS-EBV), using SUMO1-targeted short interfering RNA (siRNA).